financestockmarket

Best Stock Option to Invest In 2020

Best Stock Option to Invest In 2020

It is no news that buying a stock is relatively easy but buying the right kind of stock can be incredibly hard especially without a time-tested strategy to back up. 

With the recent rise in stocks, the market is back to an uptrend which is due mostly to the coronavirus bear market, which caused stocks to rebound powerfully. Learn stock trading strategies from day-traders.net which provides big portfolio of courses and trading strategies before you start trading.

It is time don’t you think? To know what the best stocks are right now, so you can buy them or place them on a watchlist.

Microsoft Stock

Microsoft stock has been outperforming the broader market for years and they do not disappoint as Microsoft stock is up 37% so far this year. 

Their stock holds a solid Composite Rating at 87 and earnings are a particular attraction, with the stock holding an EPS Rating of 95.

On Nov.9, Microsoft’s stocks briefly cleared a 225.31 entry point from a handle-like formation, that was too deep to be proper. Their shares later fell that day and fell again the next day, to just below their 50-day line. But since then, Microsoft now has a new, proper handle with a 228.32 buy point.

Another thing is that Microsoft has been transitioning from desktop software to the cloud and especially cloud-computing services. Demand for cloud software, in general, has risen as a result of the coronavirus pandemic. Microsoft’s most recent quarterly results beat expectations, lifted by demand for its cloud-computing offerings

Apple Stock

Apple stock has been rising for the last couple of weeks amid the election and coronavirus rallies, this is beside the fact that their relative strength line has been moving sideways since late September. But that is not to be an issue cause one unique thing about Apple stock is that it continues to produce new products. For instance, earlier this month, the firm introduced its first Mac computers with processors the company designed itself rather than those supplied by longtime partner Intel (INTC).

Read More   U.S. to announce charges against former Goldman bankers for 1MDB -WSJ

Apple stock buy point is 138.08, though investors could treat 125.49 as an early entry. Apple has a strong Composite Rating of 86 out of a best-possible 99 and has also averaged 5% growth over the past three quarters, though earnings growth is on the rise.

FedEx Stock

The global shipping giant known as FedEx has been benefitting from an e-commerce boom amid broad coronavirus lockdowns. FedEx stock is buyable after staging a rebound from its 50-day moving average and it should be noted that just last week, their stock fell 2.9%, which isn’t considered bad compared to the many e-commerce plays amid concerns that consumers might shift back to brick-and-mortar shopping as coronavirus vaccinations spread widely.

FedEx stock has a mighty Composite Rating of 95 and this boost came about after it spanked earnings estimates back in September. It snapped a streak of six consecutive quarters of EPS declines.

On another note, FedEx and Microsoft (MSFT) announced a partnership to improve shipping for commercial customers in May. They are joining forces against mutual foe Amazon. The multi-year pact will combine FedEx’s global logistics network with Microsoft’s AI and cloud expertise.

Intuitive Surgical Stock

Based on the MarketSmith analysis show, ISRG stock is looking to regain its buy point of 771.72 after breaking out of a cup-with-handle. Nevertheless, Intuitive Surgical is also close to finishing a high handle that would allow an alternate entry point of 792.64.

Their relative strength line shows a lot of promise and enthusiasm is at an all-time high. ISRG stock has an IBD Composite Rating of 76 and the IBD Stock Checkup shows that Intuitive Surgical earnings are not as strong as its stock market performance.

Read More   RBS sees first quarter profit halved

With the coronavirus epidemic taking its toll on Intuitive’s Stock, they have suffered an average EPS decline of 27% over the past three quarters. However, its earnings have grown by an average of 9% over the past three years.

At the moment, the robotic-assisted surgery provider best known for its robotic da Vinci Surgical System has the leading position in the robotic surgery space. It remains to see, however, if the competitions such as Dow Jones powerhouse Johnson & Johnson (JNJ), Medtronic (MDT), Stryker (SYK), and others developing machines; can overcome Intuitive’s leading position.

Exact Sciences Stock

The Relative Strength line of Exact Sciences stock is looking positive and has been moving strongly upwards since late August. By all accounts, this is the standout characteristic of the stock; and currently sits at a strong 90 out of 99.

Exact Sciences is working on a multi-cancer blood test that can provide early warning for six types of cancer. Medical research finds 90% success in treating people diagnosed with early-stage cancer. If it is successful, then it means a patient still gets to stay alive five years after diagnosis. But success rates tumble to 5% to 20% for those diagnosed in late stages.

The potential for a multi-cancer blood test sent Exact Sciences stock soaring 27% on September 24th, which is the day it reported positive early data. Shares spiked again on Oct. 27.

Tesla Inc

Tesla is the world’s largest automaker by market value, with a market cap of about $388 billion, and is one of the world’s leading makers of electric vehicles. It designs and manufactures fully electric vehicles, including luxury and mass-market sedans and trucks. It also is a clean energy company and produces solar energy generation and energy storage products. Tesla posted a net profit in Q3 2020, its fifth straight quarterly profit, a major improvement after a long string of financial losses in previous years. Net income rose 146.0% as revenue grew 39.2% compared to the year-ago quarter. The company produced more than 145,000 vehicles and delivered more than 139,000 in Q3 2020.

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.